Fotis Tefos

Fotis Tefos has over 8 years of experience in the healthcare industry. In 2013, they began their career at Allergan as a Market Access Manager, Ophthalmology EMEA. In 2015, they moved to GE Healthcare as a Senior Manager, Market Access Europe. Fotis returned to Allergan in 2017 as an Associate Director, International Market Access, Ophthalmology and HTA Strategy Lead, UK. In 2020, they joined AbbVie as an HTA Strategy Lead, UK. In 2021, they worked at The Janssen Pharmaceutical Companies of Johnson & Johnson as an HEMAR Lead - Early Pipeline, Retina Gene Therpay. In 2022, they joined Elios Vision as a Market Access Consultant - EU. Currently, they are working at Jazz Pharmaceuticals as Dr. Global Value & HEOR - Early Pipeline, Neuroscience and EyeYon Medical as a Market Access Consultant - EU.

Fotis Tefos holds a Master of Science in Health Economics and Policy from The London School of Economics and Political Science (LSE) and a Master of Science in Global Business Systems from Alliance Manchester Business School.